A. Arbeter

发表

Safety and cellular and humoral immune responses of a booster dose of varicella vaccine 6 years after primary immunization.

E. Rothstein, K. Reisinger, D. Clements, 1995, The Journal of infectious diseases.

An investigation of differential skin colonization of neonates by staphylococci, using an artificial neural network-based system

L. Sztandera, D. Cundell, A. Arbeter, 2002 .

An investigation of differential skin colonization of neonates by staphylococci, using an artificial neural network-based system

L. Sztandera, D. Cundell, A. Arbeter, 2002, Proceedings of the 2002 International Joint Conference on Neural Networks. IJCNN'02 (Cat. No.02CH37290).

Nutrition and infection.

J. J. Vitale, H. Vĕlez, A. Arbeter, 1971, Federation proceedings.

Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.

E. Rothstein, K. Reisinger, J. M. Jacobs, 1994, Pediatrics.

Varicella vaccine studies in healthy children and adults.

S. Plotkin, S. Starr, A. Arbeter, 1986, Pediatrics.

Life-threatening complications of varicella.

G. Fleisher, S. Plotkin, A. Arbeter, 1981, American journal of diseases of children.

Combination measles, mumps, rubella and varicella vaccine.

B. Levine, S. Plotkin, S. Starr, 1986, Pediatrics.

Varicella vaccine trials in healthy children. A summary of comparative and follow-up studies.

S. Plotkin, D. Miller, E. Proctor, 1984, American journal of diseases of children.

Live attenuated varicella vaccine: immunization of healthy children with the OKA strain.

S. Plotkin, R. Weibel, S. Starr, 1982, The Journal of pediatrics.

Neonatal blood cultures: survey of neonatologists’ practices

D. Schutzman, A. Arbeter, A. Salvador, 2012, World Journal of Pediatrics.

Clinical trials of varicella vaccine in healthy adolescents and adults.

A. Arbeter, 1996, Infectious disease clinics of North America.

Rotavirus serotype-specific neutralizing activity in human milk.

P. Offit, S. Plotkin, L. Bell, 1988, American journal of diseases of children.

Immunization of children with acute lymphoblastic leukemia with live attenuated varicella vaccine without complete suspension of chemotherapy.

B. Lange, S. Plotkin, R. Wimmer, 1990, Pediatrics.

Live attenuated varicella vaccine: the KMcC strain in healthy children.

S. Plotkin, R. Weibel, S. Starr, 1983, Pediatrics.

Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States.

M. Pichichero, D. Bernstein, E. Rothstein, 1995, Vaccine.

Human polymorphonuclear leukocyte-mediated cytotoxicity against varicella-zoster virus-infected fibroblasts

S. Douglas, M. Ito, S. Starr, 1984, Journal of virology.

Epstein‐Barr virus‐related serology in marrow transplant recipients

B. Lange, W. Henle, G. Henle, 1980, International journal of cancer.

A pediatric residency experience with surgical co-management.

M. Irigoyen, R. Wimmer, A. Arbeter, 2013, Hospital pediatrics.

Fatal recurrent Curvularia brain abscess.

L. Rorke, D. Bruce, J. Campos, 1981, The Journal of pediatrics.

Attenuated Respiratory Syncytial Virus Vaccines in Asthmatic Children

K. Mcintosh, E. Ellis, A. Arbeter, 1974, Pediatric Research.

Susceptibility of vaccine strains of varicella-zoster virus to antiviral compounds

S. Plotkin, E. Proctor, S. Starr, 1984, Antimicrobial Agents and Chemotherapy.

Inactivated mouse cytomegalovirus vaccine: preparation, immunogenicity, and protective effect.

S. Plotkin, S. Starr, A. Arbeter, 1980, The Journal of infectious diseases.

Antibody responses to influenza immunization of children with acute lymphoblastic leukemia.

B. Lange, E. Proctor, A. Arbeter, 1979, The Journal of infectious diseases.

Diffuse gastrointestinal polyposis associated with chronic blood loss, hypoproteinemia, and anasarca in an infant.

A. Arbeter, R. Courtney, M. F. Gaynor, 1970, The Journal of pediatrics.

Measles immunity: reimmunization of children who previously received live measles vaccine and gamma globulin.

K. Mcintosh, J. H. Arthur, A. Arbeter, 1972, The Journal of pediatrics.

Antibody-dependent cell-mediated cytotoxicity against varicella-zoster virus-infected targets

S. Plotkin, H. Kamiya, S. Starr, 1982, Infection and immunity.

Natural Killing of Varicella‐Zoster Virus (VZV)‐Infected Fibroblasts in Normal Children, Children with VZV Infections, and Children with Hodgkin's Disease

H. Kamiya, S. Starr, T. Ihara, 1989, Acta paediatrica Japonica : Overseas edition.

Effects of Interferon on Natural Killing and Antibody-Dependent Cellular Cytotoxicity Against Varicella-Zoster Virus-Infected and Uninfected Target Cells

S. Plotkin, S. Starr, T. Ihara, 1983 .

Serum levels of IgA1 and IgA2 in children and in patients with IgA deficiency.

M. Conley, S. Douglas, A. Arbeter, 1983, Molecular immunology.

Antibody response of low birth weight infants to Haemophilus influenzae type b polyribosylribitol phosphate-outer membrane protein conjugate vaccine.

N. Brodsky, R. Porat, A. Arbeter, 1995, Pediatrics.

Tobramycin sulfate elimination in premature infants.

S. Yaffe, S. Eisner, A. Arbeter, 1983, The Journal of pediatrics.

HCMV Envelope Antigens Induce Both Humoral and Cellular Immunity in Guinea Pigs 1

S. Plotkin, S. Starr, E. Gonczol, 1984, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Live attenuated varicella vaccine." of healthy children with the OKA Immunization strain

S. Plotkin, R. Weibel, S. Starr, 1982 .

Ancillary testing in children with rotavirus gastroenteritis.

S. Kung, A. Steenhoff, Samir S Shah, 2009, Journal of hospital medicine.

Longitudinal study of epstein‐barr virus antibody titers and excretion in pediatric patients with Hodgkin's disease

B. Lange, W. Henle, J. Hewetson, 1978, International journal of cancer.